We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

203 hedge funds and large institutions have $1.47B invested in Select Medical in 2019 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 89 increasing their positions, 53 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

645% more call options, than puts

Call options by funds: $5.14M | Put options by funds: $690K

68% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 53

2.02% less ownership

Funds ownership: 144.75%142.74% (-2%)

2% less funds holding

Funds holding: 208203 (-5)

10% less capital invested

Capital invested by funds: $1.62B → $1.47B (-$154M)

13% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 30

Holders
203
Holders Change
-5
Holders Change %
-2.4%
% of All Funds
4.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
89
Reduced
53
Closed
30
Calls
$5.14M
Puts
$690K
Net Calls
+$4.45M
Net Calls Change
-$11.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$8.52M -$167K -20,805 -2%
HM
27
HealthCor Management
New York
$8.45M +$8.95M +1,113,600 New
Prudential Financial
28
Prudential Financial
New Jersey
$8.15M +$1.49M +185,162 +21%
PCM
29
PAR Capital Management
Massachusetts
$8M
Goldman Sachs
30
Goldman Sachs
New York
$7.91M -$1.33M -165,737 -14%
Deutsche Bank
31
Deutsche Bank
Germany
$7.21M +$3.29M +408,804 +76%
Citadel Advisors
32
Citadel Advisors
Florida
$6.7M +$2.25M +279,777 +46%
Morgan Stanley
33
Morgan Stanley
New York
$6.39M -$3.09M -384,003 -31%
Bank of America
34
Bank of America
North Carolina
$6.19M +$3.67M +455,915 +127%
RA
35
Royce & Associates
New York
$5.8M +$1.29M +160,544 +27%
PPA
36
Parametric Portfolio Associates
Washington
$5M -$589K -73,286 -10%
TCIM
37
TIAA CREF Investment Management
New York
$4.65M -$25.8K -3,206 -0.5%
Legal & General Group
38
Legal & General Group
United Kingdom
$4.64M +$435K +54,087 +10%
Two Sigma Investments
39
Two Sigma Investments
New York
$4.54M +$4.81M +597,892 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$4.33M +$7.02K +873 +0.2%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$4.02M +$974K +121,197 +30%
SDIC
42
South Dakota Investment Council
South Dakota
$3.71M +$2M +248,518 +103%
TA
43
Teachers Advisors
New York
$3.64M
SEI Investments
44
SEI Investments
Pennsylvania
$3.19M +$268K +33,354 +9%
Wells Fargo
45
Wells Fargo
California
$3.14M -$682K -84,773 -17%
O
46
OppenheimerFunds
New York
$3.01M +$734K +91,319 +30%
LG
47
Leuthold Group
Minnesota
$2.87M -$544K -67,694 -15%
Swiss National Bank
48
Swiss National Bank
Switzerland
$2.78M +$86.5K +10,765 +3%
Arrowstreet Capital
49
Arrowstreet Capital
Massachusetts
$2.69M -$580K -72,206 -17%
Acadian Asset Management
50
Acadian Asset Management
Massachusetts
$2.58M -$113K -14,056 -4%

SEM Hedge Fund Activity: Q1 2019 in Review

203 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2019, worth a combined $1.47B — down 9.5% from $1.62B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of SEM and 26 opened new positions — a net loss of 4 holders — while 53 trimmed existing stakes and 89 added.

The largest buyer was T. Rowe Price Associates, adding an estimated $20.5M. The largest seller was Fisher Asset Management, exiting entirely with an estimated $48.9M sold.

  • 203 institutional investors held Select Medical (SEM) as of Q1 2019, down from 208 in Q4 2018.
  • Funds reported $1.47B of Select Medical stock for Q1 2019, down 9.5% quarter-over-quarter.
  • 26 funds opened new Select Medical positions in Q1 2019 and 30 closed out, a net change of -4 holders.
  • The largest Select Medical buyer in Q1 2019 was T. Rowe Price Associates, an estimated $20.5M added.
  • The largest Select Medical seller in Q1 2019 was Fisher Asset Management, an estimated $48.9M sold.

Based on aggregated 13F filings for Q1 2019.